Kevin Heal
Stock Analyst at Argus Research
(3.24)
# 1,044
Out of 4,711 analysts
46
Total ratings
67.74%
Success rate
8.26%
Average return
Main Sectors:
Stocks Rated by Kevin Heal
Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
---|---|---|---|---|---|---|---|
NDAQ Nasdaq | Maintains: Buy | $76 → $82 | $77.70 | +5.53% | 4 | Nov 5, 2024 | |
RF Regions Financial | Upgrades: Buy | $26 | $23.77 | +9.38% | 2 | Oct 24, 2024 | |
ZION Zions Bancorporation, National Association | Downgrades: Hold | n/a | $53.67 | - | 2 | Jul 25, 2024 | |
HBAN Huntington Bancshares | Maintains: Buy | $15 → $16 | $16.32 | -1.96% | 3 | Jul 22, 2024 | |
MET MetLife | Maintains: Buy | $77 → $80 | $81.36 | -1.67% | 2 | May 22, 2024 | |
ICE Intercontinental Exchange | Reiterates: Buy | $153 | $150.31 | +1.79% | 5 | May 21, 2024 | |
AMP Ameriprise Financial | Maintains: Buy | $440 → $460 | $532.12 | -13.55% | 1 | May 6, 2024 | |
CFG Citizens Financial Group | Maintains: Buy | $36 → $39 | $43.45 | -10.24% | 5 | Apr 24, 2024 | |
CME CME Group | Maintains: Buy | $225 → $245 | $238.53 | +2.71% | 2 | Mar 6, 2024 | |
RITM Rithm Capital | Maintains: Buy | $11 → $12 | $10.94 | +9.69% | 1 | Mar 5, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $61.16 | - | 3 | Jan 29, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $192.49 | - | 5 | Nov 16, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Hold | n/a | $11.82 | - | 3 | May 22, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $19.02 | - | 1 | Feb 21, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $9.45 | - | 1 | Feb 6, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $5.88 | - | 2 | Jun 2, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $193.56 | - | 2 | May 20, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $185 | $273.20 | -32.28% | 2 | Jul 30, 2021 |
Nasdaq
Nov 5, 2024
Maintains: Buy
Price Target: $76 → $82
Current: $77.70
Upside: +5.53%
Regions Financial
Oct 24, 2024
Upgrades: Buy
Price Target: $26
Current: $23.77
Upside: +9.38%
Zions Bancorporation, National Association
Jul 25, 2024
Downgrades: Hold
Price Target: n/a
Current: $53.67
Upside: -
Huntington Bancshares
Jul 22, 2024
Maintains: Buy
Price Target: $15 → $16
Current: $16.32
Upside: -1.96%
MetLife
May 22, 2024
Maintains: Buy
Price Target: $77 → $80
Current: $81.36
Upside: -1.67%
Intercontinental Exchange
May 21, 2024
Reiterates: Buy
Price Target: $153
Current: $150.31
Upside: +1.79%
Ameriprise Financial
May 6, 2024
Maintains: Buy
Price Target: $440 → $460
Current: $532.12
Upside: -13.55%
Citizens Financial Group
Apr 24, 2024
Maintains: Buy
Price Target: $36 → $39
Current: $43.45
Upside: -10.24%
CME Group
Mar 6, 2024
Maintains: Buy
Price Target: $225 → $245
Current: $238.53
Upside: +2.71%
Rithm Capital
Mar 5, 2024
Maintains: Buy
Price Target: $11 → $12
Current: $10.94
Upside: +9.69%
Jan 29, 2024
Downgrades: Hold
Price Target: n/a
Current: $61.16
Upside: -
Nov 16, 2023
Downgrades: Hold
Price Target: n/a
Current: $192.49
Upside: -
May 22, 2023
Upgrades: Hold
Price Target: n/a
Current: $11.82
Upside: -
Feb 21, 2023
Downgrades: Hold
Price Target: n/a
Current: $19.02
Upside: -
Feb 6, 2023
Downgrades: Hold
Price Target: n/a
Current: $9.45
Upside: -
Jun 2, 2022
Downgrades: Hold
Price Target: n/a
Current: $5.88
Upside: -
May 20, 2022
Downgrades: Hold
Price Target: n/a
Current: $193.56
Upside: -
Jul 30, 2021
Upgrades: Buy
Price Target: $185
Current: $273.20
Upside: -32.28%